ulti med Products (Deutschland) GmbH products

This kit is used for the in vitro qualitative detection of 2019-nCoV antigen. It is an immunochromatography sandwich assay, and intended to detect 2019-nCoV N-protein antigen in human nasal (NS) swab specimens. This kit can be used for individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection. A positive result indicates 2019-nCoV infection, Please quarantine yourself and contact a doctor. A PCR confirmation test is necessary. A negative result should  be treated as presumptive. It do not rule out 2019-nCoV infection. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19. Confirm with a PCR test, if necessary.

The Test Card is a lateral flow immunoassay intended for the in vitro qualitative detection of N-protein antigen from 2019-nCoV in human saliva specimens. The Test Card can be used for individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection. A positive result indicates 2019-nCoV infection, Please quarantine yourself and contact a doctor. Additional testing is necessary. Positive results do not rule out bacterial infection or co-infection with other viruses. A negative result should be treated as presumptive. It do not rule out 2019-nCoV infection. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19. Contact a doctor and Confirm with a PCR test, if necessary.

This kit is used for the in vitro qualitative detection of 2019-nCoV antigen. It is an immunochromatography sandwich assay, and intended to detect 2019-nCoV N-protein antigen in human nasal (NS) swab specimens. This kit can be used for individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection.

The ulti med Influenza A+B Antigen Test is a rapid chromatographic immunoassay for the qualitative detection of Influenza A and B antigens in nasopharyngeal swab specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.

The Single-Drug-Dip test is a rapid chromatographic immunoassay for the detection of various drugs in human urine. This assay provides only a qualitative, preliminary, analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed anayltical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. Test to monitor therapeutic measures.

GBL can be detected with the GBL Identification Substance Test by testing liquids such as alcoholic beverages. The light salty and soapy taste is often covered by the taste of the drink itself. The suspicious liquid can be easily tested through the absorbent paper which is in the front part of the Smart-Tip ™ – Probe. By breaking the capsules on the back of the test, a color reaction is triggered, which indicates the presence of GBL (K.O. drops) with a specific color.

Rapid urine drug test that screens for amphetamines, cocaine, methamphetamine, opiates, marijuana and MDMA (ecstasy). The test system is an analytical procedure used to test different types of sample materials.